Stereotaxis, Inc.

Healthcare

AMEX:STXS · New York Stock Exchange American

Market Cap $179.84M Beta 1.32 P/E (TTM) -8.4

$1.84 +1.10%

+$0.02 today

52W Low $1.70High $3.59

Vol 0.19M · Avg 0.39M

EPS (TTM)-$0.22

Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-12.80%

Period High

$3.57

Period Low

$1.73

Latest

$1.84

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

NeoGenomics, Inc.

NASDAQ:NEO

$290.37M

OraSure Technologies, Inc.

NASDAQ:OSUR

$287.79M

Sagimet Biosciences Inc.

NASDAQ:SGMT

$211.13M

Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

$198.11M

Sanara MedTech Inc.

NASDAQ:SMTI

$190.70M

Humacyte, Inc.

NASDAQ:HUMA

$177.24M

Quanterix Corporation

NASDAQ:QTRX

$146.03M

CVRx, Inc.

NASDAQ:CVRX

$133.48M

Exagen Inc.

NASDAQ:XGN

$112.83M

MDxHealth S.A.

MDXH

$27.85M

What is the latest STXS filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does STXS have?

Intrinsic Alpha currently shows 20 recent filings for STXS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.